カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界のドロスピレノン・エチニルエストラジオール錠市場2022年：エチニルエストラジオール30μg、エチニルエストラジオール20μg

◆英語タイトル：Global Drospirenone and Ethinylestradiol Tablets Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22MY8793 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年5月（※2025年版があります。お問い合わせください。） ◆ページ数：101 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：医薬品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

ドロスピレノン・エチニルエストラジオール錠市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のドロスピレノン・エチニルエストラジオール錠の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ドロスピレノン・エチニルエストラジオール錠市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・エチニルエストラジオール30μg、エチニルエストラジオール20μg

用途別セグメントは次のように区分されます。
・避妊、中等度にきび、月経前症候群（PMS）、月経前不快気分障害（PMDD）、月経困難症

世界のドロスピレノン・エチニルエストラジオール錠市場の主要な市場プレーヤーは以下のとおりです。
・Camber Pharmaceuticals、Aurobindo Pharma、Teva Generics、Glenmark Pharmaceuticals、Xiromed、Wellona Pharma、Barr Pharmaceuticals, Inc.、Hetero Drugs、MYLAN LABS LTD.、Bayer Weimar GmbH und Co. KG

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ドロスピレノン・エチニルエストラジオール錠製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なドロスピレノン・エチニルエストラジオール錠メーカーの企業概要、2019年～2022年までのドロスピレノン・エチニルエストラジオール錠の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なドロスピレノン・エチニルエストラジオール錠メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ドロスピレノン・エチニルエストラジオール錠の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのドロスピレノン・エチニルエストラジオール錠の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのドロスピレノン・エチニルエストラジオール錠市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびドロスピレノン・エチニルエストラジオール錠の産業チェーンを掲載しています。
・第13、14、15章では、ドロスピレノン・エチニルエストラジオール錠の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Camber Pharmaceuticals、Aurobindo Pharma、Teva Generics、Glenmark Pharmaceuticals、Xiromed、Wellona Pharma、Barr Pharmaceuticals, Inc.、Hetero Drugs、MYLAN LABS LTD.、Bayer Weimar GmbH und Co. KG
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：エチニルエストラジオール30μg、エチニルエストラジオール20μg
・用途別分析2017年-2028年：避妊、中等度にきび、月経前症候群（PMS）、月経前不快気分障害（PMDD）、月経困難症
・ドロスピレノン・エチニルエストラジオール錠の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・ドロスピレノン・エチニルエストラジオール錠のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・ドロスピレノン・エチニルエストラジオール錠のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・ドロスピレノン・エチニルエストラジオール錠の南米市場規模2017年-2028年：ブラジル、アルゼンチン
・ドロスピレノン・エチニルエストラジオール錠の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Drospirenone and Ethinylestradiol Tablets market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Drospirenone and Ethinylestradiol Tablets market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Birth Control accounting for % of the Drospirenone and Ethinylestradiol Tablets global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While With 30 μg Ethinylestradiol segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Drospirenone and Ethinylestradiol Tablets include Camber Pharmaceuticals, Aurobindo Pharma, Teva Generics, Glenmark Pharmaceuticals, and Xiromed, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Drospirenone and Ethinylestradiol Tablets market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
With 30 μg Ethinylestradiol
With 20 μg Ethinylestradiol
Market segment by Application can be divided into
Birth Control
Moderate Acne
Premenstrual Syndrome (PMS)
Premenstrual Dysphoric Disorder (PMDD)
Dysmenorrhea
The key market players for global Drospirenone and Ethinylestradiol Tablets market are listed below:
Camber Pharmaceuticals
Aurobindo Pharma
Teva Generics
Glenmark Pharmaceuticals
Xiromed
Wellona Pharma
Barr Pharmaceuticals, Inc.
Hetero Drugs
MYLAN LABS LTD.
Bayer Weimar GmbH und Co. KG
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Drospirenone and Ethinylestradiol Tablets product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Drospirenone and Ethinylestradiol Tablets, with price, sales, revenue and global market share of Drospirenone and Ethinylestradiol Tablets from 2019 to 2022.
Chapter 3, the Drospirenone and Ethinylestradiol Tablets competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Drospirenone and Ethinylestradiol Tablets breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Drospirenone and Ethinylestradiol Tablets market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Drospirenone and Ethinylestradiol Tablets.
Chapter 13, 14, and 15, to describe Drospirenone and Ethinylestradiol Tablets sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Drospirenone and Ethinylestradiol Tablets Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Drospirenone and Ethinylestradiol Tablets Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 With 30 μg Ethinylestradiol
1.2.3 With 20 μg Ethinylestradiol
1.3 Market Analysis by Application
1.3.1 Overview: Global Drospirenone and Ethinylestradiol Tablets Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Birth Control
1.3.3 Moderate Acne
1.3.4 Premenstrual Syndrome (PMS)
1.3.5 Premenstrual Dysphoric Disorder (PMDD)
1.3.6 Dysmenorrhea
1.4 Global Drospirenone and Ethinylestradiol Tablets Market Size & Forecast
1.4.1 Global Drospirenone and Ethinylestradiol Tablets Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Drospirenone and Ethinylestradiol Tablets Sales in Volume (2017-2028)
1.4.3 Global Drospirenone and Ethinylestradiol Tablets Price (2017-2028)
1.5 Global Drospirenone and Ethinylestradiol Tablets Production Capacity Analysis
1.5.1 Global Drospirenone and Ethinylestradiol Tablets Total Production Capacity (2017-2028)
1.5.2 Global Drospirenone and Ethinylestradiol Tablets Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Drospirenone and Ethinylestradiol Tablets Market Drivers
1.6.2 Drospirenone and Ethinylestradiol Tablets Market Restraints
1.6.3 Drospirenone and Ethinylestradiol Tablets Trends Analysis
2 Manufacturers Profiles
2.1 Camber Pharmaceuticals
2.1.1 Camber Pharmaceuticals Details
2.1.2 Camber Pharmaceuticals Major Business
2.1.3 Camber Pharmaceuticals Drospirenone and Ethinylestradiol Tablets Product and Services
2.1.4 Camber Pharmaceuticals Drospirenone and Ethinylestradiol Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Aurobindo Pharma
2.2.1 Aurobindo Pharma Details
2.2.2 Aurobindo Pharma Major Business
2.2.3 Aurobindo Pharma Drospirenone and Ethinylestradiol Tablets Product and Services
2.2.4 Aurobindo Pharma Drospirenone and Ethinylestradiol Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Teva Generics
2.3.1 Teva Generics Details
2.3.2 Teva Generics Major Business
2.3.3 Teva Generics Drospirenone and Ethinylestradiol Tablets Product and Services
2.3.4 Teva Generics Drospirenone and Ethinylestradiol Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Glenmark Pharmaceuticals
2.4.1 Glenmark Pharmaceuticals Details
2.4.2 Glenmark Pharmaceuticals Major Business
2.4.3 Glenmark Pharmaceuticals Drospirenone and Ethinylestradiol Tablets Product and Services
2.4.4 Glenmark Pharmaceuticals Drospirenone and Ethinylestradiol Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Xiromed
2.5.1 Xiromed Details
2.5.2 Xiromed Major Business
2.5.3 Xiromed Drospirenone and Ethinylestradiol Tablets Product and Services
2.5.4 Xiromed Drospirenone and Ethinylestradiol Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Wellona Pharma
2.6.1 Wellona Pharma Details
2.6.2 Wellona Pharma Major Business
2.6.3 Wellona Pharma Drospirenone and Ethinylestradiol Tablets Product and Services
2.6.4 Wellona Pharma Drospirenone and Ethinylestradiol Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Barr Pharmaceuticals, Inc.
2.7.1 Barr Pharmaceuticals, Inc. Details
2.7.2 Barr Pharmaceuticals, Inc. Major Business
2.7.3 Barr Pharmaceuticals, Inc. Drospirenone and Ethinylestradiol Tablets Product and Services
2.7.4 Barr Pharmaceuticals, Inc. Drospirenone and Ethinylestradiol Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Hetero Drugs
2.8.1 Hetero Drugs Details
2.8.2 Hetero Drugs Major Business
2.8.3 Hetero Drugs Drospirenone and Ethinylestradiol Tablets Product and Services
2.8.4 Hetero Drugs Drospirenone and Ethinylestradiol Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 MYLAN LABS LTD.
2.9.1 MYLAN LABS LTD. Details
2.9.2 MYLAN LABS LTD. Major Business
2.9.3 MYLAN LABS LTD. Drospirenone and Ethinylestradiol Tablets Product and Services
2.9.4 MYLAN LABS LTD. Drospirenone and Ethinylestradiol Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Bayer Weimar GmbH und Co. KG
2.10.1 Bayer Weimar GmbH und Co. KG Details
2.10.2 Bayer Weimar GmbH und Co. KG Major Business
2.10.3 Bayer Weimar GmbH und Co. KG Drospirenone and Ethinylestradiol Tablets Product and Services
2.10.4 Bayer Weimar GmbH und Co. KG Drospirenone and Ethinylestradiol Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Drospirenone and Ethinylestradiol Tablets Breakdown Data by Manufacturer
3.1 Global Drospirenone and Ethinylestradiol Tablets Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Drospirenone and Ethinylestradiol Tablets Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Drospirenone and Ethinylestradiol Tablets
3.4 Market Concentration Rate
3.4.1 Top 3 Drospirenone and Ethinylestradiol Tablets Manufacturer Market Share in 2021
3.4.2 Top 6 Drospirenone and Ethinylestradiol Tablets Manufacturer Market Share in 2021
3.5 Global Drospirenone and Ethinylestradiol Tablets Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Drospirenone and Ethinylestradiol Tablets Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Drospirenone and Ethinylestradiol Tablets Market Size by Region
4.1.1 Global Drospirenone and Ethinylestradiol Tablets Sales in Volume by Region (2017-2028)
4.1.2 Global Drospirenone and Ethinylestradiol Tablets Revenue by Region (2017-2028)
4.2 North America Drospirenone and Ethinylestradiol Tablets Revenue (2017-2028)
4.3 Europe Drospirenone and Ethinylestradiol Tablets Revenue (2017-2028)
4.4 Asia-Pacific Drospirenone and Ethinylestradiol Tablets Revenue (2017-2028)
4.5 South America Drospirenone and Ethinylestradiol Tablets Revenue (2017-2028)
4.6 Middle East and Africa Drospirenone and Ethinylestradiol Tablets Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Drospirenone and Ethinylestradiol Tablets Sales in Volume by Type (2017-2028)
5.2 Global Drospirenone and Ethinylestradiol Tablets Revenue by Type (2017-2028)
5.3 Global Drospirenone and Ethinylestradiol Tablets Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Drospirenone and Ethinylestradiol Tablets Sales in Volume by Application (2017-2028)
6.2 Global Drospirenone and Ethinylestradiol Tablets Revenue by Application (2017-2028)
6.3 Global Drospirenone and Ethinylestradiol Tablets Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Drospirenone and Ethinylestradiol Tablets Sales by Type (2017-2028)
7.2 North America Drospirenone and Ethinylestradiol Tablets Sales by Application (2017-2028)
7.3 North America Drospirenone and Ethinylestradiol Tablets Market Size by Country
7.3.1 North America Drospirenone and Ethinylestradiol Tablets Sales in Volume by Country (2017-2028)
7.3.2 North America Drospirenone and Ethinylestradiol Tablets Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Drospirenone and Ethinylestradiol Tablets Sales by Type (2017-2028)
8.2 Europe Drospirenone and Ethinylestradiol Tablets Sales by Application (2017-2028)
8.3 Europe Drospirenone and Ethinylestradiol Tablets Market Size by Country
8.3.1 Europe Drospirenone and Ethinylestradiol Tablets Sales in Volume by Country (2017-2028)
8.3.2 Europe Drospirenone and Ethinylestradiol Tablets Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Drospirenone and Ethinylestradiol Tablets Sales by Type (2017-2028)
9.2 Asia-Pacific Drospirenone and Ethinylestradiol Tablets Sales by Application (2017-2028)
9.3 Asia-Pacific Drospirenone and Ethinylestradiol Tablets Market Size by Region
9.3.1 Asia-Pacific Drospirenone and Ethinylestradiol Tablets Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Drospirenone and Ethinylestradiol Tablets Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Drospirenone and Ethinylestradiol Tablets Sales by Type (2017-2028)
10.2 South America Drospirenone and Ethinylestradiol Tablets Sales by Application (2017-2028)
10.3 South America Drospirenone and Ethinylestradiol Tablets Market Size by Country
10.3.1 South America Drospirenone and Ethinylestradiol Tablets Sales in Volume by Country (2017-2028)
10.3.2 South America Drospirenone and Ethinylestradiol Tablets Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Drospirenone and Ethinylestradiol Tablets Sales by Type (2017-2028)
11.2 Middle East & Africa Drospirenone and Ethinylestradiol Tablets Sales by Application (2017-2028)
11.3 Middle East & Africa Drospirenone and Ethinylestradiol Tablets Market Size by Country
11.3.1 Middle East & Africa Drospirenone and Ethinylestradiol Tablets Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Drospirenone and Ethinylestradiol Tablets Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Drospirenone and Ethinylestradiol Tablets and Key Manufacturers
12.2 Manufacturing Costs Percentage of Drospirenone and Ethinylestradiol Tablets
12.3 Drospirenone and Ethinylestradiol Tablets Production Process
12.4 Drospirenone and Ethinylestradiol Tablets Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Drospirenone and Ethinylestradiol Tablets Typical Distributors
13.3 Drospirenone and Ethinylestradiol Tablets Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Drospirenone and Ethinylestradiol Tablets Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Drospirenone and Ethinylestradiol Tablets Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Camber Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. Camber Pharmaceuticals Major Business
Table 5. Camber Pharmaceuticals Drospirenone and Ethinylestradiol Tablets Product and Services
Table 6. Camber Pharmaceuticals Drospirenone and Ethinylestradiol Tablets Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 8. Aurobindo Pharma Major Business
Table 9. Aurobindo Pharma Drospirenone and Ethinylestradiol Tablets Product and Services
Table 10. Aurobindo Pharma Drospirenone and Ethinylestradiol Tablets Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Teva Generics Basic Information, Manufacturing Base and Competitors
Table 12. Teva Generics Major Business
Table 13. Teva Generics Drospirenone and Ethinylestradiol Tablets Product and Services
Table 14. Teva Generics Drospirenone and Ethinylestradiol Tablets Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Glenmark Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 16. Glenmark Pharmaceuticals Major Business
Table 17. Glenmark Pharmaceuticals Drospirenone and Ethinylestradiol Tablets Product and Services
Table 18. Glenmark Pharmaceuticals Drospirenone and Ethinylestradiol Tablets Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Xiromed Basic Information, Manufacturing Base and Competitors
Table 20. Xiromed Major Business
Table 21. Xiromed Drospirenone and Ethinylestradiol Tablets Product and Services
Table 22. Xiromed Drospirenone and Ethinylestradiol Tablets Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Wellona Pharma Basic Information, Manufacturing Base and Competitors
Table 24. Wellona Pharma Major Business
Table 25. Wellona Pharma Drospirenone and Ethinylestradiol Tablets Product and Services
Table 26. Wellona Pharma Drospirenone and Ethinylestradiol Tablets Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Barr Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 28. Barr Pharmaceuticals, Inc. Major Business
Table 29. Barr Pharmaceuticals, Inc. Drospirenone and Ethinylestradiol Tablets Product and Services
Table 30. Barr Pharmaceuticals, Inc. Drospirenone and Ethinylestradiol Tablets Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Hetero Drugs Basic Information, Manufacturing Base and Competitors
Table 32. Hetero Drugs Major Business
Table 33. Hetero Drugs Drospirenone and Ethinylestradiol Tablets Product and Services
Table 34. Hetero Drugs Drospirenone and Ethinylestradiol Tablets Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. MYLAN LABS LTD. Basic Information, Manufacturing Base and Competitors
Table 36. MYLAN LABS LTD. Major Business
Table 37. MYLAN LABS LTD. Drospirenone and Ethinylestradiol Tablets Product and Services
Table 38. MYLAN LABS LTD. Drospirenone and Ethinylestradiol Tablets Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Bayer Weimar GmbH und Co. KG Basic Information, Manufacturing Base and Competitors
Table 40. Bayer Weimar GmbH und Co. KG Major Business
Table 41. Bayer Weimar GmbH und Co. KG Drospirenone and Ethinylestradiol Tablets Product and Services
Table 42. Bayer Weimar GmbH und Co. KG Drospirenone and Ethinylestradiol Tablets Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Global Drospirenone and Ethinylestradiol Tablets Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 44. Global Drospirenone and Ethinylestradiol Tablets Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 45. Market Position of Manufacturers in Drospirenone and Ethinylestradiol Tablets, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 46. Global Drospirenone and Ethinylestradiol Tablets Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Drospirenone and Ethinylestradiol Tablets Production Site of Key Manufacturer
Table 48. Drospirenone and Ethinylestradiol Tablets New Entrant and Capacity Expansion Plans
Table 49. Drospirenone and Ethinylestradiol Tablets Mergers & Acquisitions in the Past Five Years
Table 50. Global Drospirenone and Ethinylestradiol Tablets Sales by Region (2017-2022) & (K Units)
Table 51. Global Drospirenone and Ethinylestradiol Tablets Sales by Region (2023-2028) & (K Units)
Table 52. Global Drospirenone and Ethinylestradiol Tablets Revenue by Region (2017-2022) & (USD Million)
Table 53. Global Drospirenone and Ethinylestradiol Tablets Revenue by Region (2023-2028) & (USD Million)
Table 54. Global Drospirenone and Ethinylestradiol Tablets Sales by Type (2017-2022) & (K Units)
Table 55. Global Drospirenone and Ethinylestradiol Tablets Sales by Type (2023-2028) & (K Units)
Table 56. Global Drospirenone and Ethinylestradiol Tablets Revenue by Type (2017-2022) & (USD Million)
Table 57. Global Drospirenone and Ethinylestradiol Tablets Revenue by Type (2023-2028) & (USD Million)
Table 58. Global Drospirenone and Ethinylestradiol Tablets Price by Type (2017-2022) & (US$/Unit)
Table 59. Global Drospirenone and Ethinylestradiol Tablets Price by Type (2023-2028) & (US$/Unit)
Table 60. Global Drospirenone and Ethinylestradiol Tablets Sales by Application (2017-2022) & (K Units)
Table 61. Global Drospirenone and Ethinylestradiol Tablets Sales by Application (2023-2028) & (K Units)
Table 62. Global Drospirenone and Ethinylestradiol Tablets Revenue by Application (2017-2022) & (USD Million)
Table 63. Global Drospirenone and Ethinylestradiol Tablets Revenue by Application (2023-2028) & (USD Million)
Table 64. Global Drospirenone and Ethinylestradiol Tablets Price by Application (2017-2022) & (US$/Unit)
Table 65. Global Drospirenone and Ethinylestradiol Tablets Price by Application (2023-2028) & (US$/Unit)
Table 66. North America Drospirenone and Ethinylestradiol Tablets Sales by Country (2017-2022) & (K Units)
Table 67. North America Drospirenone and Ethinylestradiol Tablets Sales by Country (2023-2028) & (K Units)
Table 68. North America Drospirenone and Ethinylestradiol Tablets Revenue by Country (2017-2022) & (USD Million)
Table 69. North America Drospirenone and Ethinylestradiol Tablets Revenue by Country (2023-2028) & (USD Million)
Table 70. North America Drospirenone and Ethinylestradiol Tablets Sales by Type (2017-2022) & (K Units)
Table 71. North America Drospirenone and Ethinylestradiol Tablets Sales by Type (2023-2028) & (K Units)
Table 72. North America Drospirenone and Ethinylestradiol Tablets Sales by Application (2017-2022) & (K Units)
Table 73. North America Drospirenone and Ethinylestradiol Tablets Sales by Application (2023-2028) & (K Units)
Table 74. Europe Drospirenone and Ethinylestradiol Tablets Sales by Country (2017-2022) & (K Units)
Table 75. Europe Drospirenone and Ethinylestradiol Tablets Sales by Country (2023-2028) & (K Units)
Table 76. Europe Drospirenone and Ethinylestradiol Tablets Revenue by Country (2017-2022) & (USD Million)
Table 77. Europe Drospirenone and Ethinylestradiol Tablets Revenue by Country (2023-2028) & (USD Million)
Table 78. Europe Drospirenone and Ethinylestradiol Tablets Sales by Type (2017-2022) & (K Units)
Table 79. Europe Drospirenone and Ethinylestradiol Tablets Sales by Type (2023-2028) & (K Units)
Table 80. Europe Drospirenone and Ethinylestradiol Tablets Sales by Application (2017-2022) & (K Units)
Table 81. Europe Drospirenone and Ethinylestradiol Tablets Sales by Application (2023-2028) & (K Units)
Table 82. Asia-Pacific Drospirenone and Ethinylestradiol Tablets Sales by Region (2017-2022) & (K Units)
Table 83. Asia-Pacific Drospirenone and Ethinylestradiol Tablets Sales by Region (2023-2028) & (K Units)
Table 84. Asia-Pacific Drospirenone and Ethinylestradiol Tablets Revenue by Region (2017-2022) & (USD Million)
Table 85. Asia-Pacific Drospirenone and Ethinylestradiol Tablets Revenue by Region (2023-2028) & (USD Million)
Table 86. Asia-Pacific Drospirenone and Ethinylestradiol Tablets Sales by Type (2017-2022) & (K Units)
Table 87. Asia-Pacific Drospirenone and Ethinylestradiol Tablets Sales by Type (2023-2028) & (K Units)
Table 88. Asia-Pacific Drospirenone and Ethinylestradiol Tablets Sales by Application (2017-2022) & (K Units)
Table 89. Asia-Pacific Drospirenone and Ethinylestradiol Tablets Sales by Application (2023-2028) & (K Units)
Table 90. South America Drospirenone and Ethinylestradiol Tablets Sales by Country (2017-2022) & (K Units)
Table 91. South America Drospirenone and Ethinylestradiol Tablets Sales by Country (2023-2028) & (K Units)
Table 92. South America Drospirenone and Ethinylestradiol Tablets Revenue by Country (2017-2022) & (USD Million)
Table 93. South America Drospirenone and Ethinylestradiol Tablets Revenue by Country (2023-2028) & (USD Million)
Table 94. South America Drospirenone and Ethinylestradiol Tablets Sales by Type (2017-2022) & (K Units)
Table 95. South America Drospirenone and Ethinylestradiol Tablets Sales by Type (2023-2028) & (K Units)
Table 96. South America Drospirenone and Ethinylestradiol Tablets Sales by Application (2017-2022) & (K Units)
Table 97. South America Drospirenone and Ethinylestradiol Tablets Sales by Application (2023-2028) & (K Units)
Table 98. Middle East & Africa Drospirenone and Ethinylestradiol Tablets Sales by Region (2017-2022) & (K Units)
Table 99. Middle East & Africa Drospirenone and Ethinylestradiol Tablets Sales by Region (2023-2028) & (K Units)
Table 100. Middle East & Africa Drospirenone and Ethinylestradiol Tablets Revenue by Region (2017-2022) & (USD Million)
Table 101. Middle East & Africa Drospirenone and Ethinylestradiol Tablets Revenue by Region (2023-2028) & (USD Million)
Table 102. Middle East & Africa Drospirenone and Ethinylestradiol Tablets Sales by Type (2017-2022) & (K Units)
Table 103. Middle East & Africa Drospirenone and Ethinylestradiol Tablets Sales by Type (2023-2028) & (K Units)
Table 104. Middle East & Africa Drospirenone and Ethinylestradiol Tablets Sales by Application (2017-2022) & (K Units)
Table 105. Middle East & Africa Drospirenone and Ethinylestradiol Tablets Sales by Application (2023-2028) & (K Units)
Table 106. Drospirenone and Ethinylestradiol Tablets Raw Material
Table 107. Key Manufacturers of Drospirenone and Ethinylestradiol Tablets Raw Materials
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Drospirenone and Ethinylestradiol Tablets Typical Distributors
Table 111. Drospirenone and Ethinylestradiol Tablets Typical Customers
List of Figures
Figure 1. Drospirenone and Ethinylestradiol Tablets Picture
Figure 2. Global Drospirenone and Ethinylestradiol Tablets Revenue Market Share by Type in 2021
Figure 3. With 30 μg Ethinylestradiol
Figure 4. With 20 μg Ethinylestradiol
Figure 5. Global Drospirenone and Ethinylestradiol Tablets Revenue Market Share by Application in 2021
Figure 6. Birth Control
Figure 7. Moderate Acne
Figure 8. Premenstrual Syndrome (PMS)
Figure 9. Premenstrual Dysphoric Disorder (PMDD)
Figure 10. Dysmenorrhea
Figure 11. Global Drospirenone and Ethinylestradiol Tablets Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 12. Global Drospirenone and Ethinylestradiol Tablets Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Drospirenone and Ethinylestradiol Tablets Sales (2017-2028) & (K Units)
Figure 14. Global Drospirenone and Ethinylestradiol Tablets Price (2017-2028) & (US$/Unit)
Figure 15. Global Drospirenone and Ethinylestradiol Tablets Production Capacity (2017-2028) & (K Units)
Figure 16. Global Drospirenone and Ethinylestradiol Tablets Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Drospirenone and Ethinylestradiol Tablets Market Drivers
Figure 18. Drospirenone and Ethinylestradiol Tablets Market Restraints
Figure 19. Drospirenone and Ethinylestradiol Tablets Market Trends
Figure 20. Global Drospirenone and Ethinylestradiol Tablets Sales Market Share by Manufacturer in 2021
Figure 21. Global Drospirenone and Ethinylestradiol Tablets Revenue Market Share by Manufacturer in 2021
Figure 22. Drospirenone and Ethinylestradiol Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Drospirenone and Ethinylestradiol Tablets Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Drospirenone and Ethinylestradiol Tablets Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Drospirenone and Ethinylestradiol Tablets Sales Market Share by Region (2017-2028)
Figure 26. Global Drospirenone and Ethinylestradiol Tablets Revenue Market Share by Region (2017-2028)
Figure 27. North America Drospirenone and Ethinylestradiol Tablets Revenue (2017-2028) & (USD Million)
Figure 28. Europe Drospirenone and Ethinylestradiol Tablets Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Drospirenone and Ethinylestradiol Tablets Revenue (2017-2028) & (USD Million)
Figure 30. South America Drospirenone and Ethinylestradiol Tablets Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Drospirenone and Ethinylestradiol Tablets Revenue (2017-2028) & (USD Million)
Figure 32. Global Drospirenone and Ethinylestradiol Tablets Sales Market Share by Type (2017-2028)
Figure 33. Global Drospirenone and Ethinylestradiol Tablets Revenue Market Share by Type (2017-2028)
Figure 34. Global Drospirenone and Ethinylestradiol Tablets Price by Type (2017-2028) & (US$/Unit)
Figure 35. Global Drospirenone and Ethinylestradiol Tablets Sales Market Share by Application (2017-2028)
Figure 36. Global Drospirenone and Ethinylestradiol Tablets Revenue Market Share by Application (2017-2028)
Figure 37. Global Drospirenone and Ethinylestradiol Tablets Price by Application (2017-2028) & (US$/Unit)
Figure 38. North America Drospirenone and Ethinylestradiol Tablets Sales Market Share by Type (2017-2028)
Figure 39. North America Drospirenone and Ethinylestradiol Tablets Sales Market Share by Application (2017-2028)
Figure 40. North America Drospirenone and Ethinylestradiol Tablets Sales Market Share by Country (2017-2028)
Figure 41. North America Drospirenone and Ethinylestradiol Tablets Revenue Market Share by Country (2017-2028)
Figure 42. United States Drospirenone and Ethinylestradiol Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Drospirenone and Ethinylestradiol Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Drospirenone and Ethinylestradiol Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Drospirenone and Ethinylestradiol Tablets Sales Market Share by Type (2017-2028)
Figure 46. Europe Drospirenone and Ethinylestradiol Tablets Sales Market Share by Application (2017-2028)
Figure 47. Europe Drospirenone and Ethinylestradiol Tablets Sales Market Share by Country (2017-2028)
Figure 48. Europe Drospirenone and Ethinylestradiol Tablets Revenue Market Share by Country (2017-2028)
Figure 49. Germany Drospirenone and Ethinylestradiol Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Drospirenone and Ethinylestradiol Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Drospirenone and Ethinylestradiol Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Drospirenone and Ethinylestradiol Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Drospirenone and Ethinylestradiol Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Drospirenone and Ethinylestradiol Tablets Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Drospirenone and Ethinylestradiol Tablets Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Drospirenone and Ethinylestradiol Tablets Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Drospirenone and Ethinylestradiol Tablets Revenue Market Share by Region (2017-2028)
Figure 58. China Drospirenone and Ethinylestradiol Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Drospirenone and Ethinylestradiol Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Drospirenone and Ethinylestradiol Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Drospirenone and Ethinylestradiol Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Drospirenone and Ethinylestradiol Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Drospirenone and Ethinylestradiol Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Drospirenone and Ethinylestradiol Tablets Sales Market Share by Type (2017-2028)
Figure 65. South America Drospirenone and Ethinylestradiol Tablets Sales Market Share by Application (2017-2028)
Figure 66. South America Drospirenone and Ethinylestradiol Tablets Sales Market Share by Country (2017-2028)
Figure 67. South America Drospirenone and Ethinylestradiol Tablets Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Drospirenone and Ethinylestradiol Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Drospirenone and Ethinylestradiol Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Drospirenone and Ethinylestradiol Tablets Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Drospirenone and Ethinylestradiol Tablets Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Drospirenone and Ethinylestradiol Tablets Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Drospirenone and Ethinylestradiol Tablets Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Drospirenone and Ethinylestradiol Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Drospirenone and Ethinylestradiol Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Drospirenone and Ethinylestradiol Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Drospirenone and Ethinylestradiol Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Drospirenone and Ethinylestradiol Tablets in 2021
Figure 79. Manufacturing Process Analysis of Drospirenone and Ethinylestradiol Tablets
Figure 80. Drospirenone and Ethinylestradiol Tablets Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のドロスピレノン・エチニルエストラジオール錠市場2022年：エチニルエストラジオール30μg、エチニルエストラジオール20μg(Global Drospirenone and Ethinylestradiol Tablets Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界のドロスピレノン・エチニルエストラジオール錠市場2022年：エチニルエストラジオール30μg、エチニルエストラジオール20μg

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp